Orca Bio

Lead, Cell Therapy Platform

Menlo Park, California, United States

Orca Bio Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

The Lead, Cell Therapy Platform should possess a strong understanding of digital platform development and deployment, with experience in leading cross-functional teams and managing complex projects. Demonstrated ability to gather and translate business requirements into technical specifications is essential, along with a customer-centric mindset and experience in optimizing user experiences. Prior experience in the biotechnology or pharmaceutical industry is preferred, and a Bachelor’s degree in a related field is required.

Responsibilities

As the Cell Therapy Platform Lead, you will serve as the business owner of Orca Bio’s digital ordering and coordination platform, driving strategy, development, and implementation to ensure it effectively supports customer workflows such as ordering, scheduling, and delivery. You will partner closely with the technical team to convey functional requirements, manage development priorities, and oversee project execution, while also overseeing the project budget and ensuring alignment with customer needs and internal processes. Furthermore, you will lead feedback-driven improvements, implement tools and training to enhance customer support and usability, and continuously monitor platform performance and customer experience to ensure seamless integration and satisfaction.

Skills

Platform Development
Project Management
Cross-functional Collaboration
Customer Engagement
Requirements Gathering
Process Optimization
Training & Support

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI